Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    antineoplaston | Phase 3
Show Display Options
Rank Status Study
1 Not yet recruiting Effect of Antineoplaston Therapy on the QT/QTc Interval In Subjects With Diffuse, Intrinsic, Brainstem Glioma
Condition: Brain Stem Glioma
Interventions: Radiation: Radiation;   Drug: Atengenal;   Drug: Astugenal
2 Not yet recruiting Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma
Condition: Brain Stem Glioma
Interventions: Radiation: Radiation;   Drug: Atengenal;   Drug: Astugenal
3 Withdrawn Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma
Condition: Optic Nerve Glioma
Interventions: Drug: Temozolomide;   Drug: ANP Therapy

Indicates status has not been verified in more than two years